Your browser doesn't support javascript.
loading
A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning.
Nuechterlein, Keith H; Ventura, Joseph; Subotnik, Kenneth L; Gretchen-Doorly, Denise; Turner, Luana R; Casaus, Laurie R; Luo, John; Boucher, Michael L; Hayata, Jacqueline N; Bell, Morris D; Medalia, Alice.
Afiliação
  • Nuechterlein KH; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Ventura J; Department of Psychology, University of California, Los Angeles, USA.
  • Subotnik KL; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Gretchen-Doorly D; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Turner LR; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Casaus LR; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Luo J; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Boucher ML; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Hayata JN; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Bell MD; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
  • Medalia A; Department of Psychiatry, Yale University, New Haven, CT, USA.
Psychol Med ; 52(8): 1517-1526, 2022 06.
Article em En | MEDLINE | ID: mdl-32981534
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Remediação Cognitiva Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Remediação Cognitiva Idioma: En Ano de publicação: 2022 Tipo de documento: Article